Basic Information
RNALocate ID: | RLID:01001781 |
RNA Symbol: | hsa-miR-140-5p |
Localization: | Nucleus |
RNA Information
RNA Name: | hsa-miR-140 |
RNA ID: | miRBase:MIMAT0000431 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24918059 |
Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
Method: | Microarray |
Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001779 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001780 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001782 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001761 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
RLID:11001762 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001763 | Exosome | Renal cancer cells | 21670082 |
RLID:11001764 | Exosome | Breast milk | 22211110 |
RLID:11001765 | Exosome | Brain tissue | 23382797 |
RLID:11001766 | Exosome | Plasma | 23663360 |
RLID:11001767 | Exosome | Cerebrospinal fluid | 25420022 |
RLID-D:11000359 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
RLID-D:11001177 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-140-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-13465 |
MNDR | hsa-miR-140-5p | Oral squamous cell carcinoma | MNDR-E-MI-13466 |
MNDR | hsa-miR-140-5p | Large cell neuroendocrine cancer | MNDR-E-MI-13467 |
MNDR | hsa-miR-140-5p | Medulloblastoma | MNDR-E-MI-13468 |
MNDR | hsa-miR-140-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-13469 |
MNDR | hsa-miR-140-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-13470 |
MNDR | hsa-miR-140-5p | Lymphoma | MNDR-E-MI-13471 |
MNDR | hsa-miR-140-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-13472 |
MNDR | hsa-miR-140-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-13473 |
MNDR | hsa-miR-140-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-13474 |
MNDR | hsa-miR-140-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-13475 |
MNDR | hsa-miR-140-5p | Her2-receptor positive breast cancer | MNDR-E-MI-13476 |
MNDR | hsa-miR-140-5p | Niemann-pick disease type c | MNDR-E-MI-13477 |
MNDR | hsa-miR-140-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-13478 |
MNDR | hsa-miR-140-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-13479 |
MNDR | hsa-miR-140-5p | Prostate cancer | MNDR-E-MI-13480 |
MNDR | hsa-miR-140-5p | Gastric cancer | MNDR-E-MI-13481 |
MNDR | hsa-miR-140-5p | Alzheimer disease | MNDR-E-MI-13482 |
MNDR | hsa-miR-140-5p | Sickle cell anemia | MNDR-E-MI-13483 |
MNDR | hsa-miR-140-5p | Intracranial aneurysm | MNDR-E-MI-13484 |
MNDR | hsa-miR-140-5p | Urinary bladder cancer | MNDR-E-MI-13485 |
MNDR | hsa-miR-140-5p | Dysautonomia familial | MNDR-E-MI-13486 |
MNDR | hsa-miR-140-5p | Head and neck cancer | MNDR-E-MI-13487 |
MNDR | hsa-miR-140-5p | Leukemia | MNDR-E-MI-13488 |
MNDR | hsa-miR-140-5p | Cardiovascular disease | MNDR-E-MI-13489 |
MNDR | hsa-miR-140-5p | Lung cancer | MNDR-E-MI-13490 |
MNDR | hsa-miR-140-5p | Fragile x syndrome | MNDR-E-MI-13491 |
MNDR | hsa-miR-140-5p | Parkinson disease | MNDR-E-MI-13492 |
MNDR | hsa-miR-140-5p | Niemann-pick disease | MNDR-E-MI-13493 |
MNDR | hsa-miR-140-5p | Primary pulmonary hypertension | MNDR-E-MI-13494 |
MNDR | hsa-miR-140-5p | Breast cancer | MNDR-E-MI-13495 |
MNDR | hsa-miR-140-5p | Squamous cell carcinoma | MNDR-E-MI-13496 |
MNDR | hsa-miR-140-5p | Pituitary neoplasms | MNDR-E-MI-13497 |
MNDR | hsa-miR-140-5p | Pancreatic cancer | MNDR-E-MI-13498 |
MNDR | hsa-miR-140-5p | Melanoma | MNDR-E-MI-13499 |
MNDR | hsa-miR-140-5p | Rectum adenocarcinoma | MNDR-E-MI-13500 |
MNDR | hsa-miR-140-5p | Nephroblastoma | MNDR-E-MI-13501 |
MNDR | hsa-miR-140-5p | Colon cancer | MNDR-E-MI-13502 |
MNDR | hsa-miR-140-5p | Ischemic attack transient | MNDR-E-MI-13503 |
MNDR | hsa-miR-140-5p | Colon adenocarcinoma | MNDR-E-MI-13504 |
MNDR | hsa-miR-140-5p | Multiple sclerosis | MNDR-E-MI-13505 |
MNDR | hsa-miR-140-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-13506 |
MNDR | hsa-miR-140-5p | Familial ovarian cancer | MNDR-E-MI-13507 |
MNDR | hsa-miR-140-5p | Prostate adenocarcinoma | MNDR-E-MI-13508 |
MNDR | hsa-miR-140-5p | Carcinoma ductal breast | MNDR-E-MI-13509 |
MNDR | hsa-miR-140-5p | Glioblastoma | MNDR-E-MI-13510 |
MNDR | hsa-miR-140-5p | Glioma | MNDR-E-MI-13511 |
MNDR | hsa-miR-140-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-13512 |
MNDR | hsa-miR-140-5p | Osteosarcoma | MNDR-E-MI-13513 |
MNDR | hsa-miR-140-5p | Liposarcoma | MNDR-E-MI-13514 |
MNDR | hsa-miR-140-5p | Meningioma | MNDR-E-MI-13515 |
MNDR | hsa-miR-140-5p | Liver cancer | MNDR-E-MI-13516 |
MNDR | hsa-miR-140-5p | Uterine cancer | MNDR-E-MI-13517 |
MNDR | hsa-miR-140-5p | Gastric adenocarcinoma | MNDR-E-MI-13518 |
MNDR | hsa-miR-140-5p | Cervical squamous cell carcinoma | MNDR-E-MI-13519 |
MNDR | hsa-miR-140-5p | Pituitary adenoma | MNDR-E-MI-13520 |
MNDR | hsa-miR-140-5p | Lung squamous cell carcinoma | MNDR-E-MI-13521 |
MNDR | hsa-miR-140-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-13522 |
MNDR | hsa-miR-140-5p | Lung adenocarcinoma | MNDR-E-MI-13523 |
MNDR | hsa-miR-140-5p | Adrenocortical cancer | MNDR-E-MI-13524 |
MNDR | hsa-miR-140-5p | Thyroid carcinoma | MNDR-E-MI-13525 |
MNDR | hsa-miR-140-5p | Ovarian carcinoma | MNDR-E-MI-13526 |
MNDR | hsa-miR-140-5p | Bladder urothelial carcinoma | MNDR-E-MI-13527 |
MNDR | hsa-miR-140-5p | Pancreatic adenocarcinoma | MNDR-E-MI-13528 |
MNDR | hsa-miR-140-5p | Brain stem cancer | MNDR-E-MI-13529 |
MNDR | hsa-miR-140-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-13530 |
MNDR | hsa-miR-140-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-13531 |
MNDR | hsa-miR-140-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-13532 |
MNDR | hsa-miR-140-5p | Clear cell renal cell carcinoma | MNDR-E-MI-13533 |
MNDR | hsa-miR-140-5p | Large cell carcinoma | MNDR-E-MI-13534 |
MNDR | hsa-miR-140-5p | Cholangiocarcinoma | MNDR-E-MI-13535 |
MNDR | hsa-miR-140-5p | Esophageal cancer | MNDR-E-MI-13536 |
MNDR | hsa-miR-140-5p | Lung small cell carcinoma | MNDR-E-MI-13537 |
MNDR | hsa-miR-140-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-13538 |
MNDR | hsa-miR-140-5p | Testicular germ cell cancer | MNDR-E-MI-13539 |
MNDR | hsa-miR-140-5p | T acute lymphoblastic leukemia | MNDR-E-MI-13540 |
MNDR | hsa-miR-140-5p | Acute t cell leukemia | MNDR-E-MI-13541 |
MNDR | hsa-miR-140-5p | Adenoma | MNDR-E-MI-13542 |
MNDR | hsa-miR-140-5p | Breast invasive carcinoma | MNDR-E-MI-13543 |
MNDR | hsa-miR-140-5p | Hepatocellular carcinoma | MNDR-E-MI-13544 |
MNDR | hsa-miR-140-5p | Familiar ovarian carcinoma | MNDR-E-MI-13545 |
MNDR | hsa-miR-140-5p | B-cell lymphoma | MNDR-E-MI-13546 |
MNDR | hsa-miR-140-5p | Retinoblastoma | MNDR-E-MI-13547 |
MNDR | hsa-miR-140-5p | Osteoarthritis | MNDR-E-MI-13548 |
MNDR | hsa-miR-140-5p | Hypopharynx cancer | MNDR-E-MI-13549 |
MNDR | hsa-miR-140-5p | Hodgkin lymphoma | MNDR-E-MI-13550 |
MNDR | hsa-miR-140-5p | Tonsil cancer | MNDR-E-MI-13551 |
MNDR | hsa-miR-140-5p | Skin cutaneous melanoma | MNDR-E-MI-13552 |
MNDR | hsa-miR-140-5p | Skin melanoma | MNDR-E-MI-13553 |
MNDR | hsa-miR-140-5p | Acute myelocytic leukemia | MNDR-E-MI-13554 |
MNDR | hsa-miR-140-5p | Colorectal cancer | MNDR-E-MI-13555 |
MNDR | hsa-miR-140-5p | Nasopharynx carcinoma | MNDR-E-MI-13556 |
MNDR | hsa-miR-140-5p | Multiple myeloma | MNDR-E-MI-13557 |
MNDR | hsa-miR-140-5p | Acute lymphocytic leukemia | MNDR-E-MI-13558 |
MNDR | hsa-miR-140-5p | Ovarian epithelial cancer | MNDR-E-MI-13559 |
MNDR | hsa-miR-140-5p | Cardiomegaly | MNDR-E-MI-13560 |
MNDR | hsa-miR-140-5p | Nasopharyngeal cancer | MNDR-E-MI-13561 |
MNDR | hsa-miR-140-5p | Stroke lacunar | MNDR-E-MI-13562 |
MNDR | hsa-miR-140-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-13563 |
MNDR | hsa-miR-140-5p | Breast cancer her3+ negative | MNDR-E-MI-13564 |
MNDR | hsa-miR-140-5p | Hypopharyngeal carcinoma | MNDR-E-MI-13565 |
MNDR | hsa-miR-140-5p | Hypopharyngeal squamous cell carcinoma | MNDR-E-MI-13566 |
MNDR | hsa-miR-140-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-13567 |
MNDR | hsa-miR-140-5p | Tubulovillous adenoma | MNDR-E-MI-13568 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ADA | Homo sapiens | RR00039907 |
TOP